Skip to main content
. 2021 Dec 7;12(6):e02994-21. doi: 10.1128/mBio.02994-21

TABLE 1.

Demographic characteristics of GC patients (n = 49)

Variablea Value
Median age (yrs) (range) 62 (52–67)
No. (%) of patients of gender
 Male 31 (63.27)
 Female 18 (36.73)
Median BMI (kg/cm2) (range) (n = 47) 20.96 (19.31–22.50)
No. (%) of patients with tumor site
 Antrum 10 (20.41)
 Nonantrum 39 (79.59)
No. (%) of patients with histology
 Low differentiation 29 (64.44)
 Medium differentiation 3 (6.12)
 High differentiation 2 (4.08)
 Unknown 15 (30.61)
No. (%) of patients with metastasis
 Yes 26 (53.06)
 No 23 (46.94)
No. (%) of patients with liver metastasis (n = 26)
 Yes 13 (50.00)
 No 13 (50.00)
No. (%) of patients with surgery
 Yes 30 (61.22)
 No 19 (38.78)
No. (%) of patients with no. of lines of treatment of:
 <3 26 (53.06)
 ≥3 7 (14.29)
 None 16 (32.53)
No. (%) of patients with ECOG score of:
 0 29 (59.18)
 1 15 (30.61)
 2 5 (10.20)
No. (%) of patients with clinical response
 PD 17 (34.69)
 Non-PD 20 (40.82)
 Unknown 12 (24.49)
Median NLR (range) 1.91 (1.29–2.63)
Median PLR (range) 147.50 (103.94–210.09)
Median MLR (range) 0.22 (0.18–0.32)
Median CA125 (U/ml) (range) (n = 39) 23.30 (11.90–62.10)
Median CA199 (U/ml) (range) (n = 48) 7.10 (3.15–19.30)
Median CEA (μg/liter) (range) (n = 48) 1.97 (1.26–5.12)
Median CA153 (U/ml) (range) (n = 26) 7.45 (5.30–9.90)
Median ALB (g/liter) (range) 38.70 (36.10–41.75)
Median GLB (g/liter) (range) 26.20 (22.55–28.90)
Median LDH (U/liter) (range) 165.00 (146.00–183.00)
Median ALP (U/liter) (range) 85.00 (73.00–118.50)
Median progress-free survival (mos) (range) (n = 33) 6.07 (3.32–8.75)
a

Abbreviations: NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; CA125, carbohydrate antigen 125; CEA, carcinoembryonic antigen; ALB, albumin; GLB, globulin; LDH, lactate dehydrogenase; ALP, alkaline phosphatase. Range, quartiles (P25, P75).